26 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.
RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
RedHill Biopharma Ltd’s (NASDAQ:RDHL) opaganib (ABC294640), an oral drug candidate for hospitalized COVID-19 patients, demonstrated potent in vitro efficacy against…
RedHill Biopharma Announce Study Results Showing Opaganib Was Observed To Have In Vitro Efficacy Against Omicron SARS-CoV-2 Variant
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The University of
64 Biggest Movers From Yesterday
Gainers
Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co.
Redhill Biopharma Q4 Sales $22.10M Miss $24.08M Estimate
Redhill Biopharma (NASDAQ:RDHL) reported quarterly sales of $22.10 million which missed the analyst consensus estimate of $24.08 million by 8.22 percent. This is a 2.98 percent increase over sales of $21.46 million the
Redhill Biopharma’s Earnings: A Preview
Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.
Analysts estimate that Redhill Biopharma will report an earnings per share (EPS) of $-0.33.
RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea
RedHill Biopharma Ltd (NASDAQ:RDHL) has entered into an exclusive license agreement with Kukbo Co Ltd for oral opaganib to treat COVID-19 in South…
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
